Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to Telomeropathy
Clinical trial NCT03710356 · UNKNOWN
Trial details
- NCT number
- NCT03710356
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-20
- Primary completion
- 2021-10-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.